Posted on 12월 22, 202212/22/22
Pivot Pros: How EVERSANA Course Corrected When the Market Changed
Posted on 11월 16, 202211/16/22
Case Study: Benchmarking Pathway-Specific Engagement with Health Plans & Organized Providers to Identify Best Practices
Posted on 11월 3, 202211/3/22
Payer Oncology Access Management in 2022
Posted on 9월 14, 20229/14/22
Point of Attack: Developing a Targeted Oncology Account Engagement Strategy and Tactical Platform
Posted on 7월 27, 20227/27/22
Commercialization Strategies in Oncology — The Right Partner Can Reduce Risk and Boost Rewards
Posted on 1월 26, 20221/26/22
Reversing the Complexity of Oncology Commercialization: How to solve for launch challenges in a chaotic ecosystem
Posted on 1월 14, 20221/14/22
A Partnership Q&A with EVERSANA and Shorla Pharma
Posted on 1월 11, 20221/11/22
A YEAR OF ACTION: Why Data-Backed, Integrated Commercialization Strategies Are Must-haves in 2022
Posted on 11월 2, 202111/2/21